Fact CheckerSign in

NCT04945018CompletedPhase 1/2

A Study of iPS Cell-derived Cardiomyocyte Spheroids (HS-001) in Patients With Heart Failure (LAPiS Study)

A Phase I/II Study of Human Induced Pluripotent Stem (iPS) Cell-derived Cardiomyocyte Spheroids (HS-001) in Patients With Severe Heart Failure, Secondary to Ischemic Heart Disease

Source: ClinicalTrials.gov · Last updated 22 Oct 2026

Brief summary (registry, in English)

The purpose of this clinical study is to evaluate the safety and efficacy of HS-001 CS transplanted into severe heart failure patients with underlying ischemic heart disease for 26 weeks after transplantation.

Status (registry)
Completed
Phase (registry)
Phase 1/2
Study type
Interventional
Enrollment
10 (actual)
First submitted
22 Jun 2021
Start date
19 Apr 2022
Primary completion date
31 Jul 2025
Lead sponsor
Heartseed Inc.
NCT number
NCT04945018

What you commit to

  • Study type: Interventional · Phase 1/2
  • Participants enrolled: 10
  • From 19 Apr 2022 to the primary completion date, 31 Jul 2025
  • 8 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Patients screened less than 1 month after the onset of myocardial infarction
  • Patients with congenital heart disease, or cardiac sarcoidosis

Other

  • Other Criteria apply, please contact the investigator

Who the study is looking for

  • Patients with resting left ventricular ejection fraction (LVEF) ≦40% based on institutional assessment on either screening cardiac MRI or echocardiographic assessment
  • New York Heart Association (NYHA) cardiac function classification of grade II or higher at screening
  • Other Criteria apply, please contact the investigator

Age in the registry: 20 years to 80 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (8)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
St. Marianna University Hospital
Coordinator of this site? Confirm its status
KawasakiJapanUnknown status
Saitama Medical University International Medical Center
Coordinator of this site? Confirm its status
SaitamaJapanUnknown status
Juntendo University Hospital
Coordinator of this site? Confirm its status
TokyoJapanUnknown status
Tokyo Women's Medical University
Coordinator of this site? Confirm its status
TokyoJapanUnknown status
Tokyo Medical And Dental University, Medical Hospital
Coordinator of this site? Confirm its status
TokyoJapanUnknown status
Tokyo Metropolitan Geriatric Medical Center
Coordinator of this site? Confirm its status
TokyoJapanUnknown status
The University of Tokyo Hospital
Coordinator of this site? Confirm its status
TokyoJapanUnknown status
Nihon University Itabashi Hospital
Coordinator of this site? Confirm its status
TokyoJapanUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.